Abstracts
Résumé
Les élèves du primaire référés aux services scolaires complémentaires pour des troubles du comportement constituent l’une des clientèles les plus visées par la prescription de stimulants du système nerveux central (SSNC) puisque nombre d’entre eux présentent un TDAH. Il existe cependant très peu d’information permettant d’établir jusqu’à quel point la prise de SSNC est associée au TDAH chez ces élèves ou si d’autres caractéristiques contribuent à accroître la probabilité d’utilisation des SSNC. L’étude a été menée auprès de 341 élèves suivis à l’école primaire pour des troubles du comportent (27,8 % de filles, âge moyen : 9,9 ans). Les symptômes du TDAH et d’autres troubles du comportement ont été évalués à l’aide d’un instrument diagnostique utilisé auprès d’un parent et d’un enseignant. L’étude montre que 39,9 % des élèves prennent des SSNC et que, parmi les élèves qui n’ont pas de TDAH, près du tiers utilisent des stimulants. Les symptômes d’hyperactivité-impulsivité, les symptômes de trouble de l’opposition avec provocation, le groupe d’âge (6-8 ans), le statut socioéconomique (moyen-élevé) et le placement en classe spécial contribuent de manière unique à accroître la probabilité d’utiliser des SSNC. Ces résultats suggèrent donc que plusieurs caractéristiques autres que le TDAH peuvent jouer dans la décision de traiter les difficultés de ces enfants avec des SSNC. Ces résultats appellent à une meilleure évaluation du TDAH chez ces enfants de même qu’à un suivi longitudinal pour connaître les effets à long terme des SSNC sur leur adaptation scolaire.
Mots-clés :
- stimulants du système nerveux central,
- TDAH,
- troubles du comportement,
- trouble de l’opposition avec provocation,
- troubles des conduites,
- enfants d’âge scolaire primaire,
- services scolaires complémentaires
Abstract
Objectives Elementary school-aged children referred to school-based mental health services for conduct problems are commonly also prescribed central nervous system stimulants (CNSS), since many also suffer from comorbid ADHD. Nevertheless, there exists little information in the extant literature to determine to what degree the prescription of CNSS is associated with the presence of ADHD in these students or if other characteristics contribute to increasing the likelihood of CNSS use.
Methods The current study was carried out on a sample of 341 students receiving school-based mental health services for conduct problems (27.8% girls, mean age of 9.9 years). ADHD and conduct problem symptomatology was assessed using a structured diagnostic instrument administered to parents and teachers.
Results Results show that 39.9% of students were medicated using CNSS and that, among those who do not present ADHD symptomatology, approximately a third used CNSS. Age (6-8 years), socio-economic status (medium or high), placement in a special class for children with conduct problems, and symptoms of hyperactivity/impulsivity and oppositional defiant disorder all contributed unique variance in the prediction of utilisation of CNSS in this sample.
Conclusion These results suggest that there may be several characteristics other than the presence of ADHD that can contribute to the medical decision to treat child problems with CNSS. These findings also underscore the importance of more rigorous assessment of ADHD in these children as well as longitudinal follow-up studies to determine the long-term effects of CNSS on their educational performance and eventual educational attainment.
Keywords:
- central nervous system stimulants,
- ADHD,
- conduct problems,
- oppositional defiant disorder,
- elementary school-aged children,
- school-based mental health services
Appendices
Bibliographie
-
1. Comer, J. S., Olfson, M. et Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. Journal of the American Academy of Child & Adolescent Psychiatry, 49(10), 1001-1010.10.1016/j.jaac.2010.07.007 Google Scholar Search this bibliographic reference on Google Scholar
-
2. Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Magder, L., Soeken, K., … Riddle, M. A. (2003). Psychotropic practice patterns for youth : A 10-year perspective. Archives Of Pediatrics & Adolescent Medicine, 157(1), 17-25.10.1001/archpedi.157.1.17 Google Scholar Search this bibliographic reference on Google Scholar
-
3. Zuvekas, S. H. et Vitiello, B. (2012). Stimulant medication use in children : A 12-year perspective. The American Journal of Psychiatry, 169(2), 160-166. doi : 10.1176/appi.ajp.2011.1103038710.1176/appi.ajp.2011.11030387 Google Scholar Search this bibliographic reference on Google Scholar
-
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (DSM-IV) (4e éd.). Washington, DC : auteur.Google Scholar Search this bibliographic reference on Google Scholar
-
5. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (DSM-IV-TR) (4e éd., text rev.). Washington, DC : auteur.Google Scholar Search this bibliographic reference on Google Scholar
-
6. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5) (5e éd.). Washington, DC : auteur.10.1176/appi.books.9780890425596 Google Scholar Search this bibliographic reference on Google Scholar
-
7. Martin, A., Van Hoof, T., Stubbe, D., Sherwin, T. et Scahill, L. (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatric Services, 54(1), 72-77. doi : 10.1176/appi.ps.54.1.7210.1176/appi.ps.54.1.72 Google Scholar Search this bibliographic reference on Google Scholar
-
8. Déry, M., Toupin, J., Pauzé, R. et Verlaan, P. (2004). Frequency of mental health disorders in a sample of elementary school students receiving special educational services for behavioural difficulties. The Canadian Journal of Psychiatry / La Revue canadienne de psychiatrie, 49(11), 769-775.Google Scholar Search this bibliographic reference on Google Scholar
-
9. Mayes, R., Bagwell, C. et Erkulwater, J. (2008). ADHD and the rise in stimulant use among children. Harvard Review of Psychiatry, 16(3), 151-166. doi : 10.1080/1067322080216778210.1080/10673220802167782 Google Scholar Search this bibliographic reference on Google Scholar
-
10. Lafortune, D. et Collin, J. (2006). La prescription de médicaments psychotropes aux enfants et adolescents : prévalence, politiques, pratiques et pistes de recherche [Regulation of psychotropic drugs to children and teenagers : Prevalence, policies, practices and tracks of research]. Canadian Psychology/Psychologie canadienne, 47(3), 155-169. doi : 10.1037/cp200600610.1037/cp2006006 Google Scholar Search this bibliographic reference on Google Scholar
-
11. Vitiello, B. (2007). Research in child and adolescent psychopharmacology : Recent accomplishments and new challenges. Psychopharmacology, 191(1), 5-13. doi : 10.1007/s00213-006-0414-310.1007/s00213-006-0414-3 Google Scholar Search this bibliographic reference on Google Scholar
-
12. Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., … Taylor, E. (2006). Long-acting medications for the hyperkinetic disorders : A systematic review and European treatment guideline. European Child & Adolescent Psychiatry, 15(8), 476-495. doi : 10.1007/s00787-006-0549-010.1007/s00787-006-0549-0 Google Scholar Search this bibliographic reference on Google Scholar
-
13. Greenhill, L., Kollins, S., Abikoff, H., McCracken, J., Riddle, M., Swanson, J., … Cooper, T. (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 45(11), 1284-1293. doi : 10.1097/01.chi.0000235077.32661.6110.1097/01.chi.0000235077.32661.61 Google Scholar Search this bibliographic reference on Google Scholar
-
14. van der Oord, S., Prins, P. J. M., Oosterlaan, J. et Emmelkamp, P. M. G. (2008). Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD : A meta-analysis. Clinical Psychology Review, 28(5), 783-800. doi : 10.1016/j.cpr.2007.10.00710.1016/j.cpr.2007.10.007 Google Scholar Search this bibliographic reference on Google Scholar
-
15. Parens, E. et Johnston, J. (2008). Understanding the agreements and controversies surrounding childhood psychopharmacology. Child and Adolescent Psychiatry and Mental Health, 2(5). doi : 10.1186/1753-2000-2-510.1186/1753-2000-2-5 Google Scholar Search this bibliographic reference on Google Scholar
-
16. Pringsheim, T., Hirsch, L., Gardner, D. et Gorman, D. A. (2015). The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder : A systematic review and meta-analysis. Part 1 : Psychostimulants, alpha-2 agonists, and atomoxetine. The Canadian Journal of Psychiatry / La Revue canadienne de psychiatrie, 60(2), 42-51.Google Scholar Search this bibliographic reference on Google Scholar
-
17. Gouvernement du Canada. (2013). Rappels et avis de sécurité – Nouvelles mises en garde à propos de troubles cardiaques rares associés aux médicaments pour traiter le THADA. Récupéré de http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2006/13107a-fra.php?_ga=2.134479857.1637091798.1497280185-1077370674.1496932093Google Scholar Search this bibliographic reference on Google Scholar
-
18. Santé Canada. (2015). Résumé de l’examen de l’innocuité – Méthylphénidate – Suicidalité. Récupéré de http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/methylphenidate-fra.phpGoogle Scholar Search this bibliographic reference on Google Scholar
-
19. De Los Reyes, A., Augenstein, T. M., Wang, M., Thomas, S. A., Drabick, D. A. G., Burgers, D. E. et Rabinowitz, J. (2015). The validity of the multi-informant approach to assessing child and adolescent mental health. Psychological Bulletin, 141(4), 858-900. doi : 10.1037/a003849810.1037/a0038498 Google Scholar Search this bibliographic reference on Google Scholar
-
20. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). (2011). Lignes directrices canadiennes sur le TDAH, troisième édition. Toronto, Canada : CADDRA.Google Scholar Search this bibliographic reference on Google Scholar
-
21. Lafortune, D., Gagné, M.-P. et Blais, É. (2012). De l’usage rationnel à l’usage optimal des médicaments psychotropes auprès des enfants [From rational use to optimal use of psychotropic drugs among children]. Neuropsychiatrie de l’Enfance et de l’Adolescence, 60(1), 69-76. doi : 10.1016/j.neurenf.2011.05.00210.1016/j.neurenf.2011.05.002 Google Scholar Search this bibliographic reference on Google Scholar
-
22. Collin, J., Doucet, H., Lafortune, D., Monnais, L., Otero, M., Blanc, M.-È. et Proulx, M. (2005). Le médicament comme objet social et culturel : recension des écrits et propositions sur les perspectives de travail à prioriser. Québec, Canada : Le Conseil de la santé et du bien-être.Google Scholar Search this bibliographic reference on Google Scholar
-
23. Tremblay, É., Daigle, J.-M., Turgeon, M., Breton, M.-C. et Bouchard, S. (2017). Prévalence de l’usage des médicaments spécifiques au trouble du déficit de l’attention avec ou sans hyperactivité (TDAH) chez les Canadiens de 25 ans et moins. Québec, Canada : Institut national d’excellence en santé et en services sociaux. Google Scholar Search this bibliographic reference on Google Scholar
-
24. Galéra, C., Pingault, J.-B., Michel, G., Bouvard, M.-P., Melchior, M., Falissard, B.,… Côté, S. M. (2014). Clinical and social factors associated with attention-deficit hyperactivity disorder medication use : Population-based longitudinal study. The British Journal of Psychiatry, 205(4), 291-297. doi : 10.1192/bjp.bp.113.14195210.1192/bjp.bp.113.141952 Google Scholar Search this bibliographic reference on Google Scholar
-
25. Comité de revue de l’utilisation des médicaments. (2001). Étude sur les stimulants utilisés dans le traitement du trouble de déficit de l’attention/hyperactivité. Québec, Canada : gouvernement du Québec.Google Scholar Search this bibliographic reference on Google Scholar
-
26. Brault, M.-C. et Lacourse, É. (2012). Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children : 1994-2007. The Canadian Journal of Psychiatry / La Revue canadienne de psychiatrie, 57(2), 93-101.10.1177/070674371205700206 Google Scholar Search this bibliographic reference on Google Scholar
-
27. Angold, A., Erkanli, A., Egger, H. L. et Costello, E. J. (2000). Stimulant treatment for children : A community perspective. Journal of the American Academy of Child & Adolescent Psychiatry, 39(8), 975-984. doi : 10.1097/00004583-200008000-0000910.1097/00004583-200008000-00009 Google Scholar Search this bibliographic reference on Google Scholar
-
28. Garland, A. F., Brookman-Frazee, L. et Gray, E. (2013). The role of parent characteristics in community-based medication treatment for children with disruptive behavior problems. Community Mental Health Journal, 49(5), 507-514. doi : 10.1007/s10597-012-9514-110.1007/s10597-012-9514-1 Google Scholar Search this bibliographic reference on Google Scholar
-
29. Kube, D. A., Petersen, M. C. et Palmer, F. B. (2002). Attention deficit hyperactivity disorder : Comorbidity and medication use. Clinical Pediatrics, 41(7), 461-469. doi : 10.1177/00099228020410070210.1177/000992280204100702 Google Scholar Search this bibliographic reference on Google Scholar
-
30. Mattison, R. E., Rundberg-Rivera, V. et Michel, C. (2014). Psychotropic medication characteristics for special education students with emotional and/or behavioral disorders. Journal of Child and Adolescent Psychopharmacology, 24(6), 347-353. doi : 10.1089/cap.2013.007310.1089/cap.2013.0073 Google Scholar Search this bibliographic reference on Google Scholar
-
31. Tremmery, S., Buitelaar, J. K., Steyaert, J., Molenberghs, G., Feron, F. J. M., Kalff, A. C., … Jolles, J. (2007). The use of health care services and psychotropic medication in a community sample of 9-year-old schoolchildren with ADHD. European Child & Adolescent Psychiatry, 16(5), 327-336. doi : 10.1007/s00787-007-0604-510.1007/s00787-007-0604-5 Google Scholar Search this bibliographic reference on Google Scholar
-
32. Charach, A., Cao, H., Schachar, R. et To, T. (2006). Correlates of methylphenidate use in Canadian children : A cross-sectional study. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 51(1), 17-26. doi : 10.1177/070674370605100105Google Scholar Search this bibliographic reference on Google Scholar
-
33. Pavkov, T. W. et Walrath, C. M. (2008). Clinical and non-clinical characteristics associated with medication use among children with serious emotional disturbance. Journal of Child and Family Studies, 17(6), 839-852.10.1007/s10826-008-9193-2 Google Scholar Search this bibliographic reference on Google Scholar
-
34. Simon, A. E., Pastor, P. N., Reuben, C. A., Huang, L. N. et Goldstrom, I. D. (2015). Use of mental health services by children ages six to 11 with emotional or behavioral difficulties. Psychiatric Services, 66(9), 930-937. doi : 10.1176/appi.ps.20140034210.1176/appi.ps.201400342 Google Scholar Search this bibliographic reference on Google Scholar
-
35. Valla, J. P., Breton, J. J., Bergeron, L., Gaudet, N., Berthiaume, C., Saint-George, M., … Lépine, S. (1994). Enquête québécoise sur la santé mentale des jeunes de 6 à 14 ans. Rapport synthèse [Quebec Child Mental Health Survey regarding youths 6 to 14 years old. Synthesis report]. Québec, Canada : Hôpital Rivière-des-Prairies et Santé Québec.Google Scholar Search this bibliographic reference on Google Scholar
-
36. Shaffer, D., Schwab-Stone, M., Fisher, P. W., Cohen, P., Placentini, J., Davies, M., … Regier, D. (1993). The Diagnostic Interview Schedule for Children – Revised version (DISC–R) : I. Preparation, field testing, interrater reliability, and acceptability. Journal of the American Academy of Child & Adolescent Psychiatry, 32(3), 643-650. doi : 10.1097/00004583-199305000-00023Google Scholar Search this bibliographic reference on Google Scholar
-
37. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (DSM-III-R) (3e éd., révisée). Washington, DC : auteur.Google Scholar Search this bibliographic reference on Google Scholar
-
38. Breton, J.-J., Bergeron, L., Valla, J.-P., Berthiaume, C. et St-Georges, M. (1998). Diagnostic interview schedule for children (DISC-2.25) in Quebec : Reliability findings in light of the MECA study. Journal of the American Academy of Child & Adolescent Psychiatry, 37(11), 1167-1174. doi : 10.1097/00004583-199811000-00016Google Scholar Search this bibliographic reference on Google Scholar
-
39. Toupin, J. (1993). Échelle de statut socio-économique. Sherbrooke, Québec : Groupe de recherche sur les inadaptations sociales de l’enfance (GRISE).Google Scholar Search this bibliographic reference on Google Scholar
-
40. Menard, S. (2002). Applied logistic regression analysis (2e éd.). London, Royaume-Uni : Sage.10.4135/9781412983433 Google Scholar Search this bibliographic reference on Google Scholar
-
41. Hosmer, D. W. et Lemeshow, S. (2000). Interpretation of the fitted logistic regression model, in applied logistic regression (2e éd.). Hoboken, NJ : John Wiley & Sons. doi : 10.1002/0471722146.ch3Google Scholar Search this bibliographic reference on Google Scholar
-
42. Cohen, D., Clapperton, I., Gref, P. et Tremblay, Y. (1999). Déficit d’attention/hyperactivité : perceptions des acteurs et utilisation de psychostimulants. Montréal, Canada : Institut national de santé publique du Québec.Google Scholar Search this bibliographic reference on Google Scholar
-
43. d’Ambrogio, T. et Speranza, M. (2012). Approche psychopharmacologique des troubles du comportement chez l’enfant et l’adolescent [Psychopharmacological approach to behavioral disorders in children and adolescents]. Neuropsychiatrie de l’Enfance et de l’Adolescence, 60(1), 52-61. doi : 10.1016/j.neurenf.2011.10.01010.1016/j.neurenf.2011.10.010 Google Scholar Search this bibliographic reference on Google Scholar
-
44. Lloyd, B. P., Torelli, J. N. et Symons, F. J. (2016). Issues in integrating psychotropic and intensive behavioral interventions for students with emotional and behavioral challenges in schools. Journal of Emotional and Behavioral Disorders, 24(3), 148-158.10.1177/1063426616636346 Google Scholar Search this bibliographic reference on Google Scholar
-
45. Massé, L., Desbiens, N. et Lanaris, C. (2014). Le trouble de déficit de l’attention/hyperactivité. Dans L. Massé, N. Desbiens et C. Lanaris (Éd.), Les troubles du comportement à l’école. Prévention, évaluation et intervention (2e éd., p. 6-18). Montréal, Canada : Gaëtan Morin.Google Scholar Search this bibliographic reference on Google Scholar
-
46. Ministère de l’Éducation et de l’Enseignement supérieur (2016). Statistiques de l’éducation. Éducation préscolaire, enseignement primaire et secondaire. Québec, Canada : gouvernement du Québec.Google Scholar Search this bibliographic reference on Google Scholar
-
47. Ministère de l’Éducation, ministère de la Santé et des Services sociaux et ministère de la Famille et de l’Enfance (2000). TDAH trouble de déficit de l’attention/hyperactivité : agir ensemble pour mieux soutenir les jeunes : plan d’action. Québec, Canada : ministère de l’Éducation.Google Scholar Search this bibliographic reference on Google Scholar
-
48. Ministère de l’Éducation et ministère de la Santé et des Services sociaux (2003). TDAH trouble de déficit de l’attention/hyperactivité : agir ensemble pour mieux soutenir les jeunes : document de soutien à la formation : connaissances et interventions. Québec, Canada : gouvernement du Québec.Google Scholar Search this bibliographic reference on Google Scholar
-
49. Turgeon, M., Breton, M.-C., Guay, H. et Bouchard, S. (2017). Portrait de l’usage des médicaments spécifiques au trouble de déficit de l’attention avec ou sans hyperactivité (TDAH) chez les Québécois de 25 ans et moins : revue systématique sur les recommandations de bonne pratique quant à l’usage optimal des médicaments spécifiques au traitement du trouble du déficit de l’attention avec ou sans hyperactivité (TDAH) et annexes complémentaires. Québec, Canada : Institut national d’excellence en santé et en services sociaux.Google Scholar Search this bibliographic reference on Google Scholar
-
50. Romano, E., Baillargeon, R. H., Fortier, I., Wu, H.-X., Robaey, P., Zoccolillo, M. et Tremblay, R. E. (2005). Individual change in methylphenidate use in a national sample of children aged 2 to 11 years. The Canadian Journal of Psychiatry / La Revue canadienne de psychiatrie, 50(3), 144-152.Google Scholar Search this bibliographic reference on Google Scholar
